Lenvatinib mesylate857890-39-2
Product Name: lenvatinib Mesylate
Synonyms: lenvatinib Methanesulfonate;E7080 Mesylate;4-[3-Chloro-4-[[(cyclopropylamino)carbonyl]amino]phenoxy]-7-methoxy-6-quinolinecarboxamide monomethanesulfonate;4-[3chloro-4-(N'-cyclopropylureido)phenoxy]-7-methoxyquinoline-6-carboxamide methanesulfonate;CAT#A863437;Lenvatinib Mesylate,Chemical offer CAS#857890-39-2;lenvatinib Mesylate;E7080;E-7080;E 7080CAS: 857890-39-2
MF: C22H23ClN4O7
SMW: 522.95862
EINECS: 812-398-0
Lenvatinib Mesylate is a synthetic, orally available inhibitor of vascular endothelial growth factor receptor 2 (VEGFR2, also known as KDR/FLK-1) tyrosine kinase with potential antineoplastic activity. E7080 blocks VEGFR2 activation by VEGF, resulting in inhibition of the VEGF receptor signal transduction pathway, decreased vascular endothelial cell migration and proliferation, and vascular endothelial cell apoptosis.